维普中文期刊产品整合服务
362篇 您的检索式:作者名="Lok A"
    题名 作者 年代 出处 被引量
1Long-term safety of lamivudine treatment in patients with chronic hepatitis B显示文摘Anna S.F Lok Ching-Lung Lai Nancy Leung Guang-Bi Yao Zhen-Yu Cui Eugene R Schiff Jules L Dienstag E.Jenny Heathcote Nancy R Little Dorothea A Griffiths Stephen D Gardner Mary Castiglia 2003Gastroenterology2003,,6:3
2Long-term safety of lamivudine treatment in patients with chronic hepatitis B显示文摘Anna S.F Lok Ching-Lung Lai Nancy Leung Guang-Bi Yao Zhen-Yu Cui Eugene R Schiff Jules L Dienstag E.Jenny Heathcote Nancy R Little Dorothea A Griffiths Stephen D Gardner Mary Castiglia 2003Gastroenterology2003,,6:2
3An assessment of antioxidant status in patients with carbon monoxide poisoning显示文摘BACKGROUND: Carbon monoxide poisoning(COP) is an important cause of mortality and morbidity worldwide. This study was to investigate the levels of serum paraoxonase(PON), arylesterase(ARYL), ceruloplasmin(Cp), and sulfhydryl(-SH) in the treatment of COP, and to further understand the pathophysiology of COP.METHODS: This prospective study comprised 107 individuals with COP(group 1) and 50 healthy volunteers(group 2). Serum, plasma, and erythrocyte samples were taken on admission from all participants with COP. This process was repeated in the 90 th and 180 th minutes of treatment. Samples were taken from the control group only once. The levels of plasma PON, ARYL, Cp activity and-SH were measured in both groups.RESULTS: Age, gender, and carboxyhemoglobin level were not correlated with PON, ARYL, Cp, and-SH levels. PON, ARYL, and-SH levels were signifi cantly decreased in group 1 compared with group 2. Conversely, Cp was signifi cantly elevated in group 1 in contrast to group 2. Although ARYL was lower on admission in patients with COP than that was observed in the 90 th and 180 th minutes(P<0.001), Cp was higher on admission than at the other time points(P<0.001).CONCLUSIONS: Participants with COP had decreased levels of antioxidants(PON, ARLY, and-SH). COP represses the antioxidant system.Suat Zengin Behcet A Sahin Karta Basri Can Mustafa Orkmez Abdullah Taskin Ugur Lok Bediha Gulen Cuma Yildirim Seyithan Taysi 2014World Journal of Emergency Medicine2014,5,2:2
4Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis显示文摘Sophie A Jamal Ben Vandermeer Paolo Raggi David C Mendelssohn Trish Chatterley Marlene Dorgan Charmaine E Lok David Fitchett Ross T Tsuyuki 2013The Lancet2013,,:2
5Aluminophosphate molecular sieves : a new class of microporous crystalline inorganic solids显示文摘Wilson S T Lok B M Messina C A 1982J Am Chem Soc1982,104,4:1
6The acute and chronic toxicity of cadmium and zinc to two hydra species显示文摘HOLDWAY D A LOK K SEMAAN M 2001Environmental Toxicology2001,16,6:1
7Determination of enatiomeric purity of glycerides with a chiral PMR shift reagent 显示文摘Bus J Lok C M Groenewegen A 1976Chem Phys Lipids1976,16,2:1
8Nomenclature for antiviralresistant human hepatitis B virus mutations in the polymerase region 显示文摘Stuyver LJ Locarnini SA Lok A 2001Hepatology2001,33,3:1
9Chronic hepatitis B : upsate of recommen- da-tions显示文摘Lok A S McMahon B J 2004Heptology2004,39,3:1
10NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States 显示文摘Marrero J A Fontana R J Su G L Conjeevaram H S Emiek D M Lok A S 2002Hepatology2002,36,:1
11Silicoaluminophosphate molecular sieves: another new class of microporous crystalline inorganic solids 显示文摘Lok B M Messina C A Patton R L 1984J Am Chem Soc1984,106,20:1
12Nomenclature for antiviral -resistant human hepatitis B virus mutations in the polymerase region显示文摘Stuyver LJ Locarnini SA Lok A 2001Hepatology2001,33,75:1
13Chronic hepatitis B显示文摘Lok A S McMahon B J 2007Hepatology2007,45,2:1
14Expression of inflammationrelated genes in endothelial cells is not directly affected by microparticles from preeclamptic patients显示文摘Lok C A Boing A N Reitsma P H 2006J Lab Clin Med2006,147,6:1
15Tenofovir disoproxil fumarate: Role in hepatitis B treatment 显示文摘WONG S N LOK A S 2006Hepatology2006,44,2:1
16Primary renal artery dissection显示文摘Lok S Y Chalvardjian A Common A A 0,,:1
17Myopathy and neuropathy associated with nacleos(t) ide analog therapy for hepatitis B 显示文摘Fleischer R D Lok A S 2009J Hepatol2009,51,4:1
18The role of organic molecules in molecular sieve synthesis显示文摘Lok B M Cannan T R Messina C A 1983Zeolites1983,,3:1
19Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region显示文摘STUYVER LJ LOCARNINI SA LOK A 2001Hepatology2001,33,3:1
20Chronic hepatitis B显示文摘LOK A S MCMAHON B J 2007He-patology2007,45,5:1
返回顶部 每页显示:
共19页 首页 上一页 第1页 下一页 末页 /19 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费